Previous Page  6 / 46 Next Page
Information
Show Menu
Previous Page 6 / 46 Next Page
Page Background

mHSPC

Inclusion Criteria Control

Active Arm

N Primary

Endpoint

Prim

ary

com

pl.

ARCHES

NCT02677896

Naïve

or

ADT + Doc x6 <2 m

ADT/

ADT +- Doc

Ctrl +

Enza

1150 rPFS

Oct

2018

ENZAMET

NCT02446405

Naïve

ADT

/

ADT + Doc

ADT

±

Doc +

Enza

1125

OS

Sep

2020

PEACE-1

NCT01957436

Naïve

ADT + Doc

ADT + Doc +

Abi

ADT + Doc +

RT

ADT + Doc +

Abi + RT

1168 OS & rPFS

Oct

2018

TITAN

NCT02489318

Naïve* or

ADT + Doc x 6 <2 m

ADT

ADT +

Apalutamide

1052 OS & rPFS Nov

2020

ARASENS

NCT02799602

Naïve

ADT + Doc

ADT + Doc +

ODM-201

1303

OS

Aug

2022

SWOG 1216

NCT01809691

Naïve

ADT +

bicalutamide

ADT + TAK-700

1313

OS

Mar

2022

*Excludes Visceral or LN only metastasis.